Innate Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jonathan Dickinson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.7yrs
Board average tenure6yrs

Recent management updates

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Innate Pharma S.A. (EPA:IPH)

Oct 24
Risks To Shareholder Returns Are Elevated At These Prices For Innate Pharma S.A. (EPA:IPH)

Benign Growth For Innate Pharma S.A. (EPA:IPH) Underpins Its Share Price

May 21
Benign Growth For Innate Pharma S.A. (EPA:IPH) Underpins Its Share Price

Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year

Mar 24
Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year

Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Dec 21
Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher

Sep 30
Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher

Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates

Sep 16
Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates

Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Jun 09
Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts

Mar 30
News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts

Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic

Dec 18
Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic

Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?

Sep 27
Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?

Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year

Aug 04
Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year

Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

May 12
Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Apr 13
Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook

Mar 26
Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook

Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?

Nov 11
Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?

CEO

Jonathan Dickinson (56 yo)

no data

Tenure

Mr. Jonathan E. Dickinson served as Executive Vice President and General Manager of Europe at Incyte Corp. since June 2019 until October 2024. He served as General Manager of Europe/International and Senio...


Leadership Team

NamePositionTenureCompensationOwnership
Yannis Morel
Executive VP9.5yrs€599.92k0.24%
€ 277.3k
Jonathan Dickinson
Chairman of the Executive Board & CEOno datano datano data
François Romagné
Founderno datano datano data
Eric Vivier
Founder6.8yrsno data0.26%
€ 300.2k
Marc Bonneville
Founderno datano datano data
Jean Fournié
Founderno datano datano data
Alessandro Moretta
Founderno datano datano data
Frederic Lombard
Senior VP & CFO3.6yrsno data0.014%
€ 16.2k
Sonia Quaratino
Executive VPless than a yearno datano data
Arvind Sood
Executive VPless than a yearno datano data
Henry Wheeler
Vice President of Investor Relations & Communication1.8yrsno data0.0039%
€ 4.5k
Odile Belzunce
Vice President of Compliance & Operations5.8yrsno data0.077%
€ 88.9k

2.7yrs

Average Tenure

56yo

Average Age

Experienced Management: IPH's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mario Sznol
Strategic Advisory Board Member6yrsno datano data
Olivier Martinez
Member of Supervisory Boardno datano datano data
Diane Mathis
Strategic Advisory Boardless than a yearno datano data
Gilles Brisson
Independent Member of Supervisory Board17.4yrs€29.00k0.090%
€ 104.3k
Sally Bennett
Independent Supervisory Board Member2.5yrs€45.00k0.0031%
€ 3.6k
Jean-Yves Blay
Independent Member of Supervisory Board6.9yrs€29.00k0.000060%
€ 69.4
Irina Staatz-Granzer
Independent Chairwoman of Supervisory Board15.4yrs€42.00k0.031%
€ 35.8k
Pascale Boissel
Independent Vice Chairperson of the Supervisory Board4.5yrs€60.00k0.0012%
€ 1.4k
Miriam Merad
Chairman of Strategic Advisory Board6yrsno datano data
Veronique Chabernaud
Independent Member of Supervisory Board9.6yrs€48.00k0.00082%
€ 947.9
Katy Rezvani
Strategic Advisory Boardless than a yearno datano data
Aurelien Marabelle
Strategic Advisory Board Member6yrsno datano data

6.0yrs

Average Tenure

62.5yo

Average Age

Experienced Board: IPH's board of directors are considered experienced (6 years average tenure).